HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Watanabe, T Articles by Tsuneyoshi, M Search for Related Content PubMed PubMed Citation Articles by Watanabe, T Articles by Tsuneyoshi, M Pubmed/NCBI databases Substance via MeSH

Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components

¹ Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, 3–1–1 Maidashi, Higashi-ku, Fukuoka 812–8582, Japan
² >Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University

Dr Tsuneyoshi masazumi{at}surgpath.med.kyushu-u.ac.jp Aims—To compare the expression of immunohistochemical variables between benign and malignant components of malignant peripheral nerve sheath tumour (MPNST) arising within neurofibroma.

Methods—Eight cases of MPNST arising within a neurofibroma, associated with neurofibromatosis type 1 (NF1), were studied. The areas of MPNST and neurofibroma were compared immunohistochemically with regard to the expression of proliferative activity (MIB-1), growth factors, p53, bcl-2, neural cell adhesion molecule (N-CAM), and CD34.

Results—The expression of transforming growth factor ß1 (TGF-ß1), TGF-ß receptor type II, hepatocyte growth factor (HGF-), c-met, p53, and N-CAM was higher in the areas of MPNST than in the neurofibromatous areas in four, five, five, eight, five, and three of the eight cases, respectively. CD34 expression was lower in the areas of MPNST than in the neurofibroma areas in three of the eight cases.

Conclusions—On the basis of these findings, TGF-ß1, HGF-, and p53 might be involved in the malignant transformation of neurofibroma to MPNST.

Key Words: malignant peripheral nerve sheath tumour • neurofibroma • immunohistochemistry • transforming growth factor ß • hepatocyte growth factor • p53

This article has been cited by other articles:

				N. Simou, A. Zioga, A. Zygouris, D. Pahatouridis, K. Charalabopoulos, and A. Batistatou Plexiform Neurofibroma of the Cauda Equina: A Case Report and Review of the Literature International Journal of Surgical Pathology, January 1, 2008; 16(1): 78 - 80. [Abstract] [PDF]

				A. Brower, S. Salamat, J. Crawford, and P. Manley Unilateral Limb Enlargement in a Dog with a Malignant Peripheral Nerve Sheath Tumor Vet. Pathol., May 1, 2005; 42(3): 353 - 356. [Abstract] [Full Text] [PDF]